However, considering tissue specificity, following studies could further explain the mechanism of the connection between BAT and the MGBA mediated by FGF19 via the neuroendocrine aspect, and how to apply this connection to the treatment of metabolic diseases. Here, FGF19 is linked to metabolic disease.